Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:13:00.216Z.
Calculation as of: 2026-10-06T15:13:00.216Z.
Quote observation: 2026-10-06T15:10:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 564e985820cc4d82a577ec1dab8a2942c5d07d58deba224fe20754c365e89b20
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$80.89M
EV/FCF Ratio
N/A
TTM Avg
816.68x
3Y Avg
816.68x
5Y Avg
816.68x
Market Cap
$82.82M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.28M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $80.04M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | N/A | 816.68x | 816.68x | 816.68x |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | N/A | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.16M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $82.17M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.28M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $77.11M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $83.18M | N/A | 97.70x | 97.70x | 97.70x |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.74M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
